MXPA94001379A - Tratamiento selectivo de infecciones causadas por enterovirus en seres humanos. - Google Patents

Tratamiento selectivo de infecciones causadas por enterovirus en seres humanos.

Info

Publication number
MXPA94001379A
MXPA94001379A MXPA94001379A MX9401379A MXPA94001379A MX PA94001379 A MXPA94001379 A MX PA94001379A MX PA94001379 A MXPA94001379 A MX PA94001379A MX 9401379 A MX9401379 A MX 9401379A MX PA94001379 A MXPA94001379 A MX PA94001379A
Authority
MX
Mexico
Prior art keywords
humans
enteroviral
selective treatment
caused infections
infections
Prior art date
Application number
MXPA94001379A
Other languages
English (en)
Spanish (es)
Inventor
Edward J Rozhon
John F O'connell
Peter Buontempo
Stuart A Cox
Jason L Demartino
Jacquelyn M Wright
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of MXPA94001379A publication Critical patent/MXPA94001379A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
  • Medicinal Preparation (AREA)
MXPA94001379A 1993-02-26 1994-02-23 Tratamiento selectivo de infecciones causadas por enterovirus en seres humanos. MXPA94001379A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2352793A 1993-02-26 1993-02-26

Publications (1)

Publication Number Publication Date
MXPA94001379A true MXPA94001379A (es) 2011-09-26

Family

ID=21815649

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA94001379A MXPA94001379A (es) 1993-02-26 1994-02-23 Tratamiento selectivo de infecciones causadas por enterovirus en seres humanos.

Country Status (12)

Country Link
EP (1) EP0686032A1 (enExample)
JP (1) JPH08507062A (enExample)
AU (1) AU691490B2 (enExample)
CA (1) CA2156916A1 (enExample)
FI (1) FI953980L (enExample)
HU (1) HUT72490A (enExample)
IL (1) IL108749A0 (enExample)
MX (1) MXPA94001379A (enExample)
NZ (1) NZ262794A (enExample)
TW (1) TW284686B (enExample)
WO (1) WO1994018960A1 (enExample)
ZA (1) ZA941244B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210244716A1 (en) 2018-10-03 2021-08-12 Jyväskylän Yliopisto Vemurafenib and salts thereof for use in the treatment of enteroviral infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE8412799U1 (de) * 1984-04-26 1984-10-31 William Prym-Werke Kg, 5190 Stolberg SB-Verkaufsvorrichtung mit einer als Blisterpackung ausgebildeten Verkaufspackung fuer Fadenlegewerkzeuge wie Stricknadeln
EP0519702A1 (en) * 1991-06-19 1992-12-23 Schering Corporation Orally active antiviral compounds

Also Published As

Publication number Publication date
FI953980A0 (fi) 1995-08-24
HUT72490A (en) 1996-05-28
ZA941244B (en) 1994-08-23
AU691490B2 (en) 1998-05-21
FI953980A7 (fi) 1995-08-24
NZ262794A (en) 1997-03-24
WO1994018960A1 (en) 1994-09-01
JPH08507062A (ja) 1996-07-30
FI953980L (fi) 1995-08-24
TW284686B (enExample) 1996-09-01
EP0686032A1 (en) 1995-12-13
HU9502494D0 (en) 1995-10-30
AU6267994A (en) 1994-09-14
IL108749A0 (en) 1994-05-30
CA2156916A1 (en) 1994-09-01

Similar Documents

Publication Publication Date Title
SE8803486L (sv) Dosform foer behandling av kardiovaskulaera sjukdomar
EP0509019A4 (en) Treatment of human retroviral infections with 2',3'-dideoxyinosine
BR9006924A (pt) Formulacao para tratamento de sintomas e doencas,uso de formulacao para o tratamento de sintomas e doencas,metodo para o tratamento de sintomas e doencas,distribuicao de agentes medicinais e terapeuticos para o tratamento de sintomas e doencas e combinacao para administracao em mamiferos
ES2179040T3 (es) Utilizacion de 5-fluoro-2'-desoxi-3'-tiacitidina para el tratamiento de la hepatitis b.
ITRM930840A0 (it) Composizione teapeutica a base di interferone umano, impiego di interferone umano in tale composizione e relativo metodo.
ES2130114T3 (es) 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepinas y su uso en la prevencion o tratamiento de infeccion por hiv.
CO4290346A1 (es) Formas de dosificacion de liberacion controlada de azitromicina
MX9204301A (es) Acilmercaptoalcanoildipeptidos, metodos de preparacion y su uso terapeutico.
ITBO910476A0 (it) -formulazioni farmeceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali.
ATE185483T1 (de) Antivirale nucleosidkombination
FI923357A0 (fi) Framstaellning av fettsyramediciner.
GR3019514T3 (en) Pharmaceutical preparation for the treatment of prolonged coagulation time
ES2063202T3 (es) Nuevas 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepin-6-onas y -tionas y su uso en la prevencion o tratamiento del sida.
TR24895A (tr) PIRIMIDIN TüREVLERI,BUNLARIN ISTIHSAL EDILMESI VE KULLANILMASI
SE9300971D0 (sv) Hudvaardskomposition
FI941068A7 (fi) Bentsoksatsiinijohdannaiset, niiden valmistus ja terapeuttinen käyttö
NO891006D0 (no) Terapeutisk aktivt polypeptid og fremgangsmaate for dets fremstilling.
EP0313654A4 (en) MEDICINE FOR PROPHYLAXIS AND TREATMENT OF HEPATOPATHY.
ITMI911470A0 (it) N-(5-tioxo-l-prolil)-l-cisteina e suoi derivati, loro preparazione ed impiego terapeutico
ES2194104T3 (es) Uso de selegilina para el tratamiento de la perdida de audicion en mamiferos.
MXPA94001379A (es) Tratamiento selectivo de infecciones causadas por enterovirus en seres humanos.
ES2058349T3 (es) Utilizacion de betabloqueadores para el tratamiento de la progresion de la miopia axial infantil.
NO970185L (no) Anvendelse av (S)-adenosyl-L-metionin (SAMe) og dets fysiologisk kompatible salter for behandling av reperfusjonsskade utlöst av temporær-fokal-ischemi
ITMI912466A1 (it) Uso di 1, 2 dipalmitoil-l-alfa-fosfatidil-n, n-dimetiletanolammina, in composizioni dermatologiche
NO944809L (no) Biologisk aktive ureidoderivater som er nyttig i behandling av lentivirus-indusert sykdom

Legal Events

Date Code Title Description
FA Abandonment or withdrawal